Page last updated: 2024-10-17

cytosine and Bile Duct Obstruction, Intrahepatic

cytosine has been researched along with Bile Duct Obstruction, Intrahepatic in 1 studies

Research Excerpts

ExcerptRelevanceReference
" It demonstrated enhanced body weight normalized clearance of cidofovir and cidofovir dosage was augmented to 12 mg/kg per wk to reach adequate drug exposure."1.37Primary HHV 6 infection after liver transplantation with acute graft rejection and multi-organ failure: successful treatment with a 2.5-fold dose of cidofovir and reduction of immunosuppression. ( Baba, HA; Ballauf, A; Breddemann, A; Dohna-Schwake, C; Fiedler, M; Gerner, P; Gierenz, N; Hoyer, PF; Läer, S, 2011)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Dohna-Schwake, C1
Fiedler, M1
Gierenz, N1
Gerner, P1
Ballauf, A1
Breddemann, A1
Läer, S1
Baba, HA1
Hoyer, PF1

Other Studies

1 other study available for cytosine and Bile Duct Obstruction, Intrahepatic

ArticleYear
Primary HHV 6 infection after liver transplantation with acute graft rejection and multi-organ failure: successful treatment with a 2.5-fold dose of cidofovir and reduction of immunosuppression.
    Pediatric transplantation, 2011, Volume: 15, Issue:6

    Topics: Antiviral Agents; Child, Preschool; Cholestasis, Intrahepatic; Cidofovir; Cytosine; Female; Graft Re

2011